Author: anuvabiowp

  • The problem of limited diversity in genomic data

    Article goes here

  • Our co-founder Jonathan Picker on the future of genomics

    By advancing our knowledge about diseases and how we can predict effects of medicine more accurately, genomics has the power to positively impact medicine so that treatments are precise, targeted and individualized. Much progress has been made in genomics sequencing technology and practices over the last two decades. Similarly, the potential of genomics in transforming…

  • The impact of genomics on drug discovery and development

    Traditionally, drug discovery has largely been based on observational effects of chemicals on biological functions. The development of a drug being the refinement to a compound with most efficacy for least side effects. These compounds, or candidate drugs, may have arisen from biochemical understanding of processes, investigation of known phenomena such as toxicology, traditional treatments…

  • The state of genome sequencing

    Genome sequencing technologies have advanced with a remarkable pace over the last two decades. It is said that these technologies have followed, what in computer science is called, the Moore’s Law. Consider this amazing fact: The first human genome was sequenced with an investment of USD 8 Billion and 13 years of multicenter international work.…

  • Dr Jonathan Picker as new CEO

    Dr Jonathan Picker as new CEO

    “Global Gene Corp Appoints Harvard Faculty, Dr Jonathan Picker as new CEO” Global Gene Corp is delighted to announce that our Board of Directors have appointed Dr Jonathan Picker to take on the role of CEO of the Company.

×
Dr. Jonathan Picker Chief Executive Office

Dr. Jonathan Picker is an affiliate faculty member and clinical geneticist at Boston's Children's Hospital, Harvard Medical School.

With 25 years of experience in Pediatrics and Genetics, Dr. Picker specializes in the interface of clinical care and applied genetic and genomic research. Dr. Picker's research spans diagnostic tools in genetics to descriptive analysis of rare disorders to molecular neuroscience. He was the co-founder and Director of the first Pediatric Pharmacogenomic clinic in the USA; as well as Director of the Harvard Medical School Advanced Human Genetics Training Program Course.

Dr. Picker is the recipient of various prestigious awards, including the first Sidney R. Baer Jr. Prize for Mental health Research. He has authored numerous research papers involving informative cases, molecular biology, behavioral neuroscience, applied clinical genetic guidelines as well as invited reviews and chapters.

Dr. Picker holds a bachelor's degree of Medical Biology in Genetics, and an MBChB in Medicine from Aberdeen University, UK. He also holds an MS in Genetics and Biochemistry and a PhD in Molecular Biology from Newcastle University, UK.

×
Kushagra SharmaPresident & Board Member

Kushagra Sharma is a seasoned business leader with a career spanning entrepreneurship as well as general management, Kushagra has deep expertise in developing and executing business plans in start-ups as well as large corporations. He is responsible for the revenue growth of the business, strategic planning, and partnerships at Anuva.

Before joining Anuva, he was responsible for the strategy and project execution in launching 4G digital services for Reliance Jio in India. Kushagra has previously served in leadership roles in companies like British Telecom, MTS Sistema Shyam, Grail Research and Evalueserve.

He holds a bachelor's degree from Indian Institute of Technology, Delhi and an MBA from INSEAD, Fontainebleau.

×
Dr. Asmi ShahVice President of Data and Technology

Dr. Asmi Shah brings in her data science expertise in dealing with big data, managing and standardizing multidisciplinary large scale biological datasets in the field of drug discovery through genomics and phenomics. She is responsible for the research and development of end to end software products and workflows.

Before joining Anuva, she contributed to the research of drug discovery done with the use of high content/throughput screening on various zebrafish assays at University of Heidelberg in Germany and at Harvard Medical School, USA. She has also taken up various technical roles in product management and software R&D with different corporate industries such as Intel, Rambus and Inform Technologies in the USA and with data analytics startups in India.

Dr. Shah holds a bachelor’s degree from Saurashtra University, India, an MS from San Jose State University, USA and has pursued her PhD from University of Heidelberg, Germany under a Marie Curie fellowship.

×
Abhishek Kumar Chairman & Executive Director

Abhishek Kumar brings in extensive experience of acquiring, merging, carving out and repositioning companies globally. He founded Joulon - a KKR company, and has led large scale distributed businesses globally.

He holds a bachelor’s degree from Indian Institute of Technology, Kanpur and an MBA from Harvard Business School.